dc.contributor.author |
Bedke, Jens |
de_DE |
dc.contributor.author |
Stenzl, Arnulf |
de_DE |
dc.date.accessioned |
2014-02-03T14:21:46Z |
|
dc.date.available |
2014-02-03T14:21:46Z |
|
dc.date.issued |
2013 |
de_DE |
dc.identifier.issn |
1473-7140 |
de_DE |
dc.identifier.uri |
http://hdl.handle.net/10900/40417 |
|
dc.language.iso |
en |
en |
dc.publisher |
Expert Reviews |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1586/14737140.2013.856761 |
de_DE |
dc.rights |
info:eu-repo/semantics/closedAccess |
|
dc.subject.ddc |
610 |
de_DE |
dc.title |
Immunotherapeutic strategies for the treatment of renal cell carcinoma: where are we now? |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20140116051827_00082 |
de_DE |
utue.publikation.seiten |
1399-1408 |
de_DE |
utue.personen.roh |
Bedke, Jens |
de_DE |
utue.personen.roh |
Stenzl, Arnulf |
de_DE |
dcterms.isPartOf.ZSTitelID |
Expert Review of Anticancer Therapy |
de_DE |
dcterms.isPartOf.ZS-Issue |
12 |
de_DE |
dcterms.isPartOf.ZS-Volume |
13 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |